{"id":"W3171658130","doi":"10.1200/jco.2021.39.15_suppl.e14026","title":"Combination olaparib and durvalumab for patients with recurrent IDH-mutated gliomas.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Olaparib; PARP inhibitor; Medicine; Glioma; Isocitrate dehydrogenase; Cancer research; Durvalumab; Cancer; Oncology; Internal medicine; Poly ADP ribose polymerase; Immunotherapy; Biology; Nivolumab; Polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002615404,0.000645745,0.001089375,0.0002477574,0.000162453,0.0003956517,0.0004226555,0.0003860586,0.002277177],"category_scores_gemma":[0.0002540048,0.0001876168,0.0004965225,0.0003446064,0.0001448335,0.0002802719,0.0001772465,0.0007790501,0.0007280043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000718876,"about_ca_system_score_gemma":0.0006060699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007471706,"about_ca_topic_score_gemma":0.003735502,"domain_scores_codex":[0.9999062,0.00002270363,0.000009416931,0.00001713428,0.00001545562,0.00002900096],"domain_scores_gemma":[0.9998922,0.00001491779,0.00002398242,0.000006034913,0.000005596898,0.0000572912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2008228,0.005812789,0.03467735,0.001963549,0.002040493,0.004245386,0.0002275643,0.003819453,0.04975975,0.0009418371,0.01909258,0.6765963],"study_design_scores_gemma":[0.3233353,0.2693866,0.2097948,0.0006258248,0.003833415,0.03667366,0.0003013236,0.01180041,0.02518992,0.002544354,0.1163334,0.0001810441],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9709255,0.01517718,0.0006801362,0.001086189,0.0002022602,0.0006393293,0.001859476,0.0001604469,0.009269522],"genre_scores_gemma":[0.9902762,0.003642553,0.000817645,0.0006030043,0.00009466598,0.0002435806,0.002135791,0.00001743065,0.00216921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002277177,"threshold_uncertainty_score":0.007617891,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07358273245928833,"score_gpt":0.4347585393750165,"score_spread":0.3611758069157282,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}